Yahoo Finance Today’s Research Reports on Trending Tickers: BioCryst Pharmaceuticals and 22nd Century Group
NEW YORK, NY / ACCESSWIRE / December 11, 2017 / U.S. markets were lifted Friday by a stronger-than-expected November jobs report, sending the Dow and the S&P 500 to new record highs. The Dow Jones Industrial Average gained 0.49 percent to close at 24,329.16, while the S&P 500 Index rose 0.55 percent to close at 2,651.50. The Nasdaq Composite Index increased 0.40 percent to close at 6,840.08. On Friday, The Labor Department reported nonfarm payrolls increased by approximately 228,000 in November, which topped expectations of an increase of 200,000, according to economists surveyed by Reuters.
"I thought the jobs report was really good. It's hard to argue with anything on there, except the low level of wage growth gives us some pause," said J.J. Kinahan, chief market strategist at TD Ameritrade, according to MarketWatch. "Wage growth is a conundrum, and that will make the Fed's upcoming statement really interesting. We have to see what they say about inflation because we’re just not getting it."
RDI Initiates Coverage on:
BioCryst Pharmaceuticals, Inc.
https://rdinvesting.com/news/?ticker=BCRX
22nd Century Group, Inc.
https://rdinvesting.com/news/?ticker=XXII
BioCryst Pharmaceuticals, Inc.'s stock jumped 14.00% Friday, to close the day at $5.21. The stock recorded a trading volume of 3,231,308 shares, which was above its three months average volume of 1,498,175 shares. In the last year, BioCryst Pharmaceuticals, Inc.'s shares have traded in a range of 3.95 - 9.25. The share price has gained 31.90% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $4.63 is below its 200-day moving average of $5.11. Shares of BioCryst Pharmaceuticals have gained roughly 8.09 percent in the past month and are down 17.69 percent year-to-date.
Access RDI's BioCryst Pharmaceuticals, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=BCRX
On Friday, shares in 22nd Century Group, Inc. recorded a trading volume of 5,866,874 shares, which was above the three months average volume of 3,809,862 shares. The stock ended the day 9.96% higher at 2.65. The share price has gained 227.16% from its 52-week low with a 52-week trading range of 0.81 - 3.50.The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $2.29 is greater than its 200-day moving average of $2.18. Shares of 22nd Century Group have gained roughly 28.64 percent in the past month and are up 143.12 percent year-to-date.
Access RDI's 22nd Century Group, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=XXII
Our Actionable Research on BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) and 22nd Century Group, Inc. (NYSEAMERICAN:XXII) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
